Company Filing History:
Years Active: 2019-2024
Title: Niall M Hamilton: Innovator in Cancer Research
Introduction
Niall M Hamilton is a prominent inventor based in Manchester, GB. He has made significant contributions to the field of cancer research, holding a total of 6 patents. His work focuses on developing innovative compounds that target specific enzyme activities related to proliferative disorders.
Latest Patents
Hamilton's latest patents include groundbreaking inventions such as PARG inhibitory compounds. These compounds function as inhibitors of the PARG (Poly ADP-ribose glycohydrolase) enzyme activity. The invention also encompasses processes for preparing these compounds, pharmaceutical compositions containing them, and their application in treating proliferative disorders like cancer. Another notable patent is for autotaxin inhibitory compounds, which are designed to inhibit autotaxin (ATX) enzyme activity. Similar to his PARG compounds, this invention includes processes for preparation, pharmaceutical compositions, and potential uses in treating conditions such as cancer and fibrosis.
Career Highlights
Niall M Hamilton is associated with Cancer Research Technology Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating therapeutic solutions that address critical health challenges.
Collaborations
Hamilton collaborates with esteemed colleagues, including Allan Michael Jordan and James R Hitchin, to further enhance the impact of his research in the field of cancer treatment.
Conclusion
Niall M Hamilton's innovative contributions to cancer research through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic options in the fight against cancer and other proliferative disorders.